title: CoMFA analyses of C-2 position salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity.
abstract: The highly potent and kappa-opioid (KOP) receptor-selective hallucinogen Salvinorin A and selected analogs have been analyzed using the 3D quantitative structure-affinity relationship technique Comparative Molecular Field Analysis (CoMFA) in an effort to derive a statistically significant and predictive model of salvinorin affinity at the KOP receptor and to provide additional statistical support for the validity of previously proposed structure-based interaction models. Two CoMFA models of Salvinorin A analogs substituted at the C-2 position are presented. Separate models were developed based on the radioligand used in the kappa-opioid binding assay, [(3)H]diprenorphine or [(125)I]6 beta-iodo-3,14-dihydroxy-17-cyclopropylmethyl-4,5 alpha-epoxymorphinan ([(125)I]IOXY). For each dataset, three methods of alignment were employed: a receptor-docked alignment derived from the structure-based docking algorithm GOLD, another from the ligand-based alignment algorithm FlexS, and a rigid realignment of the poses from the receptor-docked alignment. The receptor-docked alignment produced statistically superior results compared to either the FlexS alignment or the realignment in both datasets. The [(125)I]IOXY set (Model 1) and [(3)H]diprenorphine set (Model 2) gave q(2) values of 0.592 and 0.620, respectively, using the receptor-docked alignment, and both models produced similar CoMFA contour maps that reflected the stereoelectronic features of the receptor model from which they were derived. Each model gave significantly predictive CoMFA statistics (Model 1 PSET r(2)=0.833; Model 2 PSET r(2)=0.813). Based on the CoMFA contour maps, a binding mode was proposed for amine-containing Salvinorin A analogs that provides a rationale for the observation that the beta-epimers (R-configuration) of protonated amines at the C-2 position have a higher affinity than the corresponding alpha-epimers (S-configuration).
authors.affiliation: Department of Medicinal Chemistry, P.O. Box 980540, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298-0540, USA.
authors.forename: Donna L
authors.initials: DL
authors.lastname: McGovern
authors.forename: Philip D
authors.initials: PD
authors.lastname: Mosier
authors.forename: Bryan L
authors.initials: BL
authors.lastname: Roth
authors.forename: Richard B
authors.initials: RB
authors.lastname: Westkaemper
mesh_terms: D002244:Carbon / Q000737:chemistry*; D004174:Diprenorphine / Q000737:chemistry; D045785:Diterpenes, Clerodane / Q000737:chemistry*; D006801:Humans; D016014:Linear Models; D008958:Models, Molecular; D011437:Propylamines / Q000737:chemistry; D021281:Quantitative Structure-Activity Relationship; D017473:Receptors, Opioid, kappa / Q000737:chemistry*; D013237:Stereoisomerism
chemical_list: D045785:Diterpenes, Clerodane; D011437:Propylamines; D017473:Receptors, Opioid, kappa; D004174:Diprenorphine; D002244:Carbon; C035263:2-propylamine; C090499:salvinorin A